登录 | 注册    关注公众号  
微信公众号
搜索
 > 【LIF R】

LIF R信息

英文名称:Leukemia inhibitory factor receptor
中文名称:白血病抑制因子受体
靶点别称:LIF receptor,LIF-R,CD118
上市药物数量:0
临床药物数量:1
最高研发阶段:临床二期

LIF R产品列表

产品库
物种
标签
属性
货号 物种 产品描述 蛋白结构 纯度 活性
LIR-H4252
Human
Human LIF R / CD118 Protein, Fc Tag
ACRO质量管理体系
 
评论(0)
 

LIF R分子别名

LIFR,CD118,FLJ98106,FLJ99923,SJS2,STWS,SWS

LIF R分子背景

Leukemia inhibitory factor receptor is also known as LIFR; CD118; FLJ98106; FLJ99923; LIF-R; SJS2; STWS; SWS, is the receptor for leukemia inhibitory factor (LIF). The leukemia inhibitory factor is a polyfunctional cytokine that affects the differentiation, survival, and proliferation of a wide variety of cells in the adult and the embryo. LIF action appears to be mediated through a high-affinity receptor complex composed of a low-affinity LIF binding chain (LIF receptor) and a high-affinity converter subunit, gp130. Both LIFR and gp130 are members of a family of cytokine receptors that includes components of the receptors for the majority of hematopoietic cytokines and for cytokines that affect other systems, including the ciliary neurotrophic factor, growth hormone and prolactin Defects in LIFR are the cause of Stueve-Wiedemann syndrome (SWS), a severe autosomal recessive condition and belongs to the group of the bent-bone dysplasias.

LIF R临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
Cardiotrophin-1 (Digna Biotech/Biotecnol) CT-1 临床二期 Biotecnol Sa, Digna Biotech Sl, 基因泰克 肝功能衰竭, 急性肾损伤, 心脏再灌注损伤, 缺血 详情

消息提示

请输入您的联系方式,再点击提交!

确定